4//SEC Filing
BIENAIME JEAN JACQUES 4
Accession 0001415889-24-015552
CIK 0001664710other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:11 PM ET
Size
5.4 KB
Accession
0001415889-24-015552
Insider Transaction Report
Form 4
BIENAIME JEAN JACQUES
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-03+17,600→ 17,600 totalExercise: $48.67Exp: 2034-06-02→ Common Stock (17,600 underlying)
Footnotes (1)
- [F1]One-twelfth (1/12th) of the shares subject to the option shall vest in equal quarterly installments commencing on September 3, 2024, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001221590
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:11 PM ET
- Size
- 5.4 KB